Kyle Malady serves as Executive at DEXCOM INC, where they oversee executive responsibilities. Since joining the company, Kyle Malady has executed 53 insider transactions totaling $2.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 3, 2019 involved selling 926 shares valued at $52.7K.
Kyle Malady currently holds 84,926 shares of DEXCOM INC (DXCM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyle Malady has been a net seller of DXCM stock. They have purchased $0 and sold $2.4M worth of shares.
Kyle Malady's most recent insider trade was on Mar 3, 2019, when they sold 926 shares at $56.96 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 22, 2019 | VZ | $95.2K | Payment | 1,673 | $56.92 | Discretionary |